<DOC>
	<DOCNO>NCT02422810</DOCNO>
	<brief_summary>The purpose study characterize new test ass rate time take form blood clot people either take aspirin .</brief_summary>
	<brief_title>High-Shear Microfluidic Thrombosis Assay</brief_title>
	<detailed_description>It estimate approximately 25 % people resistant aspirin , respond effect . These individual four fold high risk heart attack stroke compare respond aspirin . Current test determine aspirin resistant reliable . This study assess effectiveness new assay determine rate time take people aspirin form blood clot .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Inclusion Criteria `` aspirin '' group : take aspirin , nonsteroidal antiinflammatory drug ( NSAIDs ) , clopidogrel previous 10 day history myocardial infarction , ischemic stroke , ischemic event Inclusion Criteria `` aspirin daily '' group : take aspirin daily last 10 day history myocardial infarction , ischemic stroke , ischemic event Inclusion Criteria `` new aspirin '' group : previously prescribe aspirin , prescribe aspirin present appointment , e.g . high calcium plaque score CT history myocardial infarction , ischemic stroke , ischemic event know bleed thrombotic disorder Exclusion Criteria `` new aspirin '' group : know bleed thrombotic disorder take aspirin , NSAIDs , clopidogrel , anticoagulant previous 10 day</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>